We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Applied Biosystems Completes Acquisition of the Research Products Division of Ambion
News

Applied Biosystems Completes Acquisition of the Research Products Division of Ambion

Applied Biosystems Completes Acquisition of the Research Products Division of Ambion
News

Applied Biosystems Completes Acquisition of the Research Products Division of Ambion

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Applied Biosystems Completes Acquisition of the Research Products Division of Ambion"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Applied Biosystems Group, and Applera Corporation business, has announced that it has completed the previously announced acquisition of the Research Products Division of Ambion, Inc.

"We are excited about the many opportunities for sales growth and new products that we anticipate as a result of this strategic acquisition," said Catherine M. Burzik, president of Applied Biosystems.

"We welcome Ambion's employees and anticipate a smooth integration of product lines and personnel as we accelerate the delivery of more complete workflow solutions to our global customer base."

The research and development, manufacturing, and other operations of Ambions Research Products Division will continue to be based in Austin, Texas and its approximately 300 employees will be integrated into the Applied Biosystems global workforce of approximately 4,000 employees.

Ambion will become a center of excellence within the Molecular Biology Divisions consumables business with a focus on expanding the range of consumables products in the Applied Biosystems portfolio.

Recent Ambion product introductions include reagents associated with microRNA and RNA interference.

Advertisement